Risk factors for severe COVID-19 outcomes in a large US health care system
Fecal transplant throws new light on inflammatory bowel disease
3 June 2022Officials find 2 monkeypox strains in US
3 June 2022Risk factors for severe COVID-19 outcomes in a large US health care system
The risk of acquiring COVID-19—and the severity of illness—in the context of immune-mediated inflammatory diseases (IMIDs) and their therapy, remains incompletely understood. Reported infection rates and outcomes have varied depending on the specific IMID, the nature and size of the study population, and the presence or absence of appropriate control populations.
